Wednesday, February 10, 2010, 8:09pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEFINANCE NEWS
    Market:       |  

Parexel International Corp. (PRXL)

At 5:00AM SGT: 19.25 USD   0.00 (0.00%)  
 MORE ON PRXL 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 PAREXEL International Corporati (NasdaqNM:PRXL) Delayed quote dataEdit
Last Trade:19.25 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:19.25
Open:N/A
Bid:13.75 x 500
Ask:N/A
1y Target Est:17.00
Day's Range:N/A - N/A
52wk Range:7.20 - 21.10
Volume:0
Avg Vol (3m):550,713
Market Cap:1.12B
P/E (ttm):29.21
EPS (ttm):0.66
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add PRXL to Portfolio   Download Data

 HEADLINES 
PAREXEL INTERNATIONAL CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Sat, Feb 6)
Biologic And Diagnostic Device Research And Development Expenditures Drive Stock Winners With Or Without Congressional Legislation According To Northland Securities
Wall Street Transcript (Thu, Jan 28)
Leading Lymphoma Expert Joins Perceptive Informatics Team of Medical Imaging Scientific Advisors
PR Newswire (Wed, Jan 27)
PAREXEL International Corporation F2Q10 (Qtr End 12/31/09) Earnings Call Transcript
at Seeking Alpha (Wed, Jan 27)
Parexel hits annual high on 2Q results and demand
AP (Wed, Jan 27)
Parexel ups guidance after strong Q2
at bizjournals.com (Tue, Jan 26)
PAREXEL Earnings Call scheduled for 10:00 am ET today
CCBN (Tue, Jan 26)
Early-Market Movers: VMware, Weatherford International
at Fox Business (Tue, Jan 26)
New Star Analyst Rankings for PAREXEL International Corporati
StarMine (Tue, Jan 26)
PAREXEL INTERNATIONAL CORP Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Tue, Jan 26)
More Headlines for PRXL...

 ANALYST 
EPS Est (next year) (Jun-10) :0.94
EPS Est (in 2 years) (Jun-11) :1.17
Avg Rec (current)*:2.0
PEG Ratio:1.38
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
PAREXEL International Corporation, a biopharmaceutical services company, provides clinical research, medical communications services, consulting and informatics, and technology products and services to the pharmaceutical, biotechnology, and medica...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
Latest NewsSingapore Indices